Surgery for brain metastases without dexamethasone around the operation
Tests skipping dexamethasone around surgery in adults with newly found brain metastases.
Key facts
- Who runs it
- University of Louisville
- Where
- Louisville, United StatesSee the site
- Trial code
- Registry title
- MeDex: No Perioperative Dexamethasone in Brain Metastases
- Status
- Recruiting
- People taking part
- 35 people, planned
- Started
- 1 Aug 2026
- Expected to end
- Oct 2027
- Type of study
- Interventional
- Treatments tested
- Withholding perioperative Dexamethasone
- Record updated
- 29 May 2026
Who can take part
The trial is looking for adults with newly found brain metastases (cancer spread to the brain) who are planned for surgery to remove them. They will have surgery without the steroid dexamethasone (Dex).
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- New brain tumor(s) on imaging and a mass in a body organ suspected or confirmed to be cancer. Brain surgery (craniotomy) is planned to remove more than 75% of the tumor. ECOG performance status ≤ 2 (up and about more than 50% of waking hours). Midline shift on MRI ≤ 10 mm.
- Earlier treatment
- Must never have received Dex. No steroid use in the past month. People with a lung mass and no prior diagnosis must have a lung biopsy before brain surgery.
- Main reasons for not taking part
- Brain metastases that cannot be removed by surgery and are over 2 cm (0.8 in), or more than 4 such metastases
- Treatment with laser interstitial thermal therapy (LITT), or high concern for primary CNS lymphoma
- Small cell lung carcinoma
- A condition that needs steroids
- Stage 4 chronic kidney disease (GFR<30), or being pregnant or breastfeeding
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- New brain tumor(s) on imaging
- Visceral mass(es) suspicious or confirmed for neoplasm; Patients with lung mass suspicious for primary lung cancer and no prior diagnosis must undergo biopsy of the lung mass prior to resection of brain metastasis(es) to exclude histology (i.e., small cell lung carcinoma) that would not benefit from resection
- No contraindications for craniotomy
- Age ≥ 18 years
- ECOG performance status ≤ 2 (i.e., ambulatory > 50% of waking hours)
- Midline shift on MRI ≤ 10 mm
- Craniotomy planned to resect >75% of the enhancing mass (surgeon's judgment)
Who cannot take part
- Presence of BMs not eligible for resection that are each > 2 cm in any one dimension
- >4 BMs not eligible for resection that are each 2 cm in any one dimension
- Treatment with laser interstitial thermal therapy (LITT)
- Steroid use in the past month
- A condition that requires steroids
- Stage 4 chronic kidney disease (GFR<30)
- High concern for primary CNS lymphoma
- Diagnosis of small cell lung carcinoma
- Any receipt of Dex
- Pregnant or breastfeeding
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Brain metastases
This trial is currently available in United States.
- University of Louisville HospitalLouisville, United StatesContact: Mechelle Kaufman, BSNTaking people
About the trial
What the trial wants to find out
Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
The group in the trial
- Withholding perioperative dexamethasoneTreatment being tested
The safety and feasibility of withholding perioperative dexamethasone (Dex) in newly diagnosed cancer patients undergoing resection of brain metastases (BMs). The primary question is not comparative efficacy, but rather whether it is safe to forgo Dex in this patient population.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- MeDex: No Perioperative Dexamethasone in Brain Metastases
- Plain-language title
- Surgery for brain metastases without dexamethasone around the operationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07044557, who can take part
- Record updated
- 29 May 2026